Literature DB >> 11355843

Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography.

V A Simon1, M D Thiam, L C Lipford.   

Abstract

Two high-performance liquid chromatographic methods using UV detection are presented for the determination of two different groups (A and B) of drugs used in the suppression of human immunodeficiency virus (HIV). Group A is comprised of six nucleosidic reverse transcriptase inhibitors, viz. zalcitabine, lamivudine, stavudine, didanosine, zidovudine and ziagen. Group B consists of seven drugs four of which are protease inhibitors (PIs) and three of which are non-nucleosidic reverse transcriptase inhibitors (NNRTIs). The PIs are: indinavir, nelfinavir, saquinavir and ritonavir. The NNRTIs are: nevirapine, delavirdine and efavirenz. Groups A and B require separate aliquots of serum for extraction and must be chromatographed separately.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355843     DOI: 10.1016/s0021-9673(00)01092-x

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients.

Authors:  Nitin Charbe; Sara Baldelli; Valeria Cozzi; Simone Castoldi; Dario Cattaneo; Emilio Clementi
Journal:  J Pharm Anal       Date:  2016-06-14

2.  A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasma.

Authors:  Praveen Srivastava; Ganesh S Moorthy; Robert Gross; Jeffrey S Barrett
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.